Measurement of the coronary artery diameter adjusted by the body surface area in the follow-up of Kawasaki disease
HUI Wei, GUI Yong-Hao
Abstract No abstract available
Cite this article:
HUI Wei,GUI Yong-Hao. Measurement of the coronary artery diameter adjusted by the body surface area in the follow-up of Kawasaki disease[J]. 中国当代儿科杂志, 2001, 3(5): 534-536.
HUI Wei,GUI Yong-Hao. Measurement of the coronary artery diameter adjusted by the body surface area in the follow-up of Kawasaki disease[J]. CJCP, 2001, 3(5): 534-536.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2001/V3/I5/534
[1]
YUAN Ying-Di, SUN Jun, LI Peng-Fei, WEI Chun-Lei, YU Yan-Hui. Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease
[2]
GUO Li, LU Mei-Ping, DONG Gui-Juan, TENG Li-Ping, XU Yi-Ping, ZOU Li-Xia, ZHENG Qi. Clinical and laboratory features of macrophage activation syndrome
[3]
SUN Rui-Li, ZHU Shu-Xia, ZHANG Yan-Yan, WU Yi-Fei, WANG Xing-Jian. Changes in peripheral blood T helper 9 cells and interleukin-9 in children in the acute stage of Kawasaki disease
[4]
ZHAO Jian-Mei, WANG Qian. Role of triggering receptor expressed on myeloid cells-1 in the pathogenesis of Kawasaki disease
[5]
LI Jing, WANG Bo-Long, FENG Rui-Bing, LI Guo-Dong. Efficacy of glucocorticoids combined with immunoglobulin in initial treatment of Kawasaki disease: a Meta analysis
[6]
ZHANG Yuan-Da, LI Rong-Min, JI Chao-Yu, ZHANG Xiao-Long, ZHANG Yu, DONG Qing-Wei, MA Lei. Changes in 25-hydroxyvitamin D3 level and its significance in children with Kawasaki disease
[7]
YANG Xue, DONG Xiang-Yu. Research advances in association between vitamin D and Kawasaki disease and related mechanisms of action
[8]
PENG Chang, LUO Yue-Jing, XING Qian-Lu, XIAO Ming-Chen. Clinical features of children with incomplete Kawasaki disease
[9]
WANG Zhi-Jian, ZHU Mei-Hua, ZHANG Li, CHEN Jun-Chu, ZHU Li-Ling, LIANG Min, PENG Yun. Renal artery injury caused by Kawasaki disease
[10]
DENG Yong-Chao, WANG Xun, TANG Xi-Chun, HUANG Cai-Zhi, YANG Juan, MO Li-Ya. Risk factors for coronary artery lesions secondary to Kawasaki disease in children
[11]
ZHAO Dong-Mei, YIN Qian-Li, JI Xue-Hong, Mierzhati HAIWEIER, MENG Guang-Yu, CHENG Qiu-Ting, JU Li-Juan. Glucocorticoid combined with ulinastatin in treatment of Kawasaki disease in children: a non-randomized controlled clinical trial
[12]
JIN Xiang-Qun, LIU Pin, ZHANG Qiu-Ping. Genetic susceptibility in children with incomplete Kawasaki disease
[13]
LIU Fan, DING Yan, YIN Wei. Association of single nucleotide polymorphisms in TARC/CCL17 gene with Kawasaki disease and its clinical characteristics
[14]
CHEN Ting-Ting, SHI Kun, LIU Yi-Ling, GUO Yong-Hong, LI Yan, WANG Xian-Min. Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease
[15]
XIAO Yun-Bin, CHEN Zhi, HUANG Xi-Yong, WANG Xiang, WANG Xun, YANG Zhou. Transcatheter closure in various types of congenital coronary artery fistula: a followup study
